Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,617 | 248 | 96.4% |
| Education | $208.75 | 6 | 3.6% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,102 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $474.07 | 26 | $0 (2024) |
| Dornier MedTech America, Inc | $390.59 | 1 | $0 (2023) |
| PFIZER INC. | $335.78 | 21 | $0 (2024) |
| ABBVIE INC. | $307.81 | 21 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $252.14 | 11 | $0 (2024) |
| Teleflex LLC | $244.43 | 5 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $202.14 | 8 | $0 (2020) |
| UROGEN PHARMA, INC. | $191.67 | 7 | $0 (2024) |
| Antares Pharma, Inc. | $178.34 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $804.49 | 32 | PROGENICS PHARMACEUTICALS, INC. ($135.64) |
| 2023 | $1,022 | 28 | Dornier MedTech America, Inc ($390.59) |
| 2022 | $743.16 | 32 | Teleflex LLC ($188.16) |
| 2021 | $634.93 | 33 | Astellas Pharma US Inc ($286.41) |
| 2020 | $94.57 | 3 | Endo Pharmaceuticals Inc. ($80.62) |
| 2019 | $800.64 | 45 | Astellas Pharma US Inc ($182.12) |
| 2018 | $714.91 | 41 | Astellas Pharma US Inc ($175.20) |
| 2017 | $1,011 | 49 | Astellas Pharma US Inc ($253.68) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunotherapy | ||||||
| 10/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/15/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Olympus America Inc. | URETERO-RENO VIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Urology Gynecology | ||||||
| 08/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/15/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/26/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NONE | ||||||
| 06/21/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Urology Gynecology | ||||||
| 06/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $113.77 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $74.12 | General |
| Category: Urology | ||||||
| 04/17/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/20/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/13/2024 | COLOPLAST CORP | Porges Coloplast (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Endourology | ||||||
| 03/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: HORMONE THERAPY | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $72.01 | General |
| Category: Oncology | ||||||
| 02/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/31/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,909 | 8,017 | $1.1M | $234,421 |
| 2022 | 27 | 3,822 | 6,990 | $1.2M | $228,598 |
| 2021 | 28 | 3,808 | 10,962 | $1.2M | $249,496 |
| 2020 | 26 | 3,383 | 8,359 | $771,286 | $187,494 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 715 | 895 | $238,070 | $60,146 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 511 | $153,811 | $48,474 | 31.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 429 | 499 | $132,235 | $23,475 | 17.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 172 | 219 | $95,265 | $14,136 | 14.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 33 | 36 | $190,180 | $12,412 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $36,000 | $10,770 | 29.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 80 | 197 | $32,702 | $10,501 | 32.1% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 16 | 2,650 | $13,250 | $5,990 | 45.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 404 | 564 | $34,404 | $4,895 | 14.2% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 21 | 61 | $23,790 | $4,674 | 19.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 33 | 34 | $21,080 | $4,360 | 20.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 57 | 101 | $12,726 | $4,083 | 32.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 41 | 41 | $16,851 | $3,575 | 21.2% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 14 | 16 | $21,280 | $3,524 | 16.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 33 | 33 | $18,975 | $3,524 | 18.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 949 | 1,508 | $7,540 | $3,306 | 43.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 246 | 311 | $6,206 | $2,592 | 41.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 24 | $26,400 | $2,499 | 9.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $8,091 | $2,421 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 40 | $10,640 | $2,103 | 19.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 20 | 20 | $8,420 | $1,908 | 22.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 37 | $5,365 | $1,862 | 34.7% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 29 | $4,727 | $1,516 | 32.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 44 | 44 | $14,300 | $1,143 | 8.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 14 | $1,960 | $385.33 | 19.7% |
About Dr. Jordan Angell, MD
Dr. Jordan Angell, MD is a Urology healthcare provider based in Westminster, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/31/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306021076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jordan Angell, MD has received a total of $5,826 in payments from pharmaceutical and medical device companies, with $804.49 received in 2024. These payments were reported across 263 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($5,617).
As a Medicare-enrolled provider, Angell has provided services to 14,922 Medicare beneficiaries, totaling 34,328 services with total Medicare billing of $900,010. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Westminster, MD
- Active Since 12/31/2007
- Last Updated 05/27/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1306021076
Products in Payments
- XTANDI (Drug) $658.30
- Dornier MedTech (Device) $390.59
- PROVENGE (Drug) $252.14
- Myrbetriq (Drug) $222.45
- Erleada (Drug) $220.29
- UROLIFT (Device) $211.73
- XIAFLEX (Biological) $202.14
- ORGOVYX (Drug) $193.46
- JELMYTO (Drug) $191.67
- MYRBETRIQ (Drug) $187.33
- Xtandi (Drug) $181.07
- ERLEADA (Drug) $156.61
- Androgel (Drug) $150.76
- ZYTIGA (Drug) $139.58
- Prolia (Biological) $139.27
- PYLARIFY (Drug) $135.64
- ELIGARD (Drug) $127.57
- Urolift - UL400 (Device) $126.81
- FIRMAGON (Drug) $126.73
- XYOSTED (Drug) $107.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Westminster
Dr. Michael Davenport, Md, MD
Urology — Payments: $56,404
Dr. Robert Segal, M.d, M.D
Urology — Payments: $25,217
Michael Ferrandino, Md, MD
Urology — Payments: $23,444
Brian Levin, M.d, M.D
Urology — Payments: $7,439
Dr. Keith Oreilly, M.d, M.D
Urology — Payments: $6,873
Dr. Michael Kane, M.d, M.D
Urology — Payments: $2,570